Results 141 to 150 of about 581 (153)

A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, 4‐Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants

Clinical Pharmacology in Drug Development, 2021
exaly  

PROCESS FOR PREPARATION OF SOLRIAMFETOL AND INTERMEDIATES THEREOF

2021
KAMBLE VIKAS SHIVAJI, RANANAWARE UMESH BABANRAO, SHIVDAVKAR RADHAKRISHNA BHIKAJI, SINGH GIRIJ PAL   +3 more
openaire   +1 more source

Methods of administering solriamfetol to lactating women

2023
openaire   +12 more sources

PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF

2020
BHIRUD SHEKHAR BHASKAR, NAIK SAMIR, MISHRA SUSHANTA K, KAWTHEKAR RAHUL BHALCHADRARAO, PATEKAR DEEPAK SHANTARAM, PATIL NITESH   +5 more
openaire   +1 more source

A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food

Clinical Therapeutics, 2019
exaly  

Clinical Trial of Solriamfetol in Early Morning Shift Workers

Sleep Medicine
K.-M. Zitting, K.R. Gilmore, B.J. Lockyer, E.B. Leary, W. Wang, N.C. Issa, S.F. Quan, J.S. Williams, J.F. Duffy, C.A. Czeisler   +9 more
openaire   +1 more source

First fluorescence method for monitoring the doping stimulant drug solriamfetol in plasma and urine: A pharmacokinetic study in volunteers’ urine with greenness, whiteness, and blueness assessments

Microchemical Journal
Hend Z Yamani, Lobna A Hussein
exaly  

Solriamfetol (Sunosi) for excessive daytime sleepiness.

The Medical letter on drugs and therapeutics, 2019
openaire   +1 more source

Methods of providing solriamfetol therapy to subjects with impaired renal function

2021
openaire   +18 more sources

Solriamfetol improves symptoms in myalgic encephalomyelitis/chronic fatigue

The Brown University Psychopharmacology Update
openaire   +1 more source